Skip to main content
. 2019 Dec 21;25(47):6799–6812. doi: 10.3748/wjg.v25.i47.6799

Table 3.

Graft survival is similar in HCV-negative recipients of livers from HCV NAT-positive or -negative donors (Data from Cotter et al[40])

1-yr 2-yr
DNAT-/R- 93% 88%
DNAT-/R+ 93% 88%
DNAT+/R- 93% 86%
DNAT+/R+ 94% 90%

DNAT: Donor HCV NAT status; R: Recipient HCV NAT status.